HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motonobu Nakamura Selected Research

carpronium (carpronium chloride)

10/2002Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motonobu Nakamura Research Topics

Disease

23Neoplasms (Cancer)
01/2022 - 01/2010
21Drug Eruptions (Drug Eruption)
07/2021 - 08/2009
16Prostatic Neoplasms (Prostate Cancer)
04/2022 - 08/2012
13Carcinoma (Carcinomatosis)
10/2022 - 12/2017
12Neoplasm Metastasis (Metastasis)
01/2022 - 01/2015
8Melanoma (Melanoma, Malignant)
02/2022 - 04/2010
7Inflammation (Inflammations)
01/2022 - 07/2014
7Lymphatic Metastasis
06/2021 - 06/2010
7Psoriasis (Pustulosis Palmaris et Plantaris)
02/2020 - 05/2014
7Insulin Resistance
03/2017 - 05/2011
7Hypertension (High Blood Pressure)
03/2017 - 01/2014
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2021 - 02/2011
6Renal Cell Carcinoma (Grawitz Tumor)
03/2021 - 08/2014
5Skin Diseases (Skin Disease)
01/2022 - 07/2009
5Alopecia Areata
01/2022 - 10/2002
4Skin Neoplasms (Skin Cancer)
11/2021 - 02/2011
4Dermatitis
01/2018 - 05/2012
4Contact Dermatitis (Eczema, Contact)
10/2015 - 08/2002
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
07/2013 - 04/2011
3Obesity
01/2022 - 05/2021
3Disease Progression
01/2022 - 12/2017
3Pain (Aches)
01/2020 - 01/2015
3Atopic Dermatitis (Atopic Eczema)
11/2019 - 07/2012
3Exfoliative Dermatitis (Erythroderma)
08/2018 - 05/2009
3Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2017 - 03/2015
3Erythema
12/2016 - 05/2008
3Pseudolymphoma
05/2016 - 05/2009
3Pruritus (Itching)
07/2014 - 02/2011
3Urticaria (Hives)
01/2014 - 11/2010
3Necrosis
01/2012 - 07/2009
3Alopecia (Baldness)
12/2011 - 06/2005
2Acute Kidney Injury (Acute Renal Failure)
10/2022 - 07/2012
2Diarrhea
02/2022 - 10/2013
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 02/2018
2Breast Neoplasms (Breast Cancer)
01/2022 - 10/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2021
2Infections
11/2021 - 11/2016
2Stevens-Johnson Syndrome (Lyell's Syndrome)
07/2021 - 05/2014
2Merkel Cell Carcinoma
05/2021 - 07/2013
2Bullous Pemphigoid (Pemphigoid)
07/2020 - 06/2011

Drug/Important Bio-Agent (IBA)

10pembrolizumabIBA
10/2022 - 01/2020
9PlatinumIBA
10/2022 - 02/2018
8NivolumabIBA
02/2022 - 01/2015
8Pharmaceutical PreparationsIBA
01/2022 - 05/2009
7Insulin (Novolin)FDA Link
03/2017 - 01/2010
6cabazitaxelFDA Link
06/2021 - 01/2019
6CytokinesIBA
05/2021 - 03/2008
6SodiumIBA
03/2017 - 01/2015
5Prednisolone (Predate)FDA LinkGeneric
02/2022 - 12/2011
5Therapeutic UsesIBA
01/2021 - 06/2005
5Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 11/2014
4Biomarkers (Surrogate Marker)IBA
10/2022 - 06/2021
4Immune Checkpoint InhibitorsIBA
02/2022 - 11/2020
4Proteins (Proteins, Gene)FDA Link
07/2021 - 03/2012
4Paclitaxel (Taxol)FDA LinkGeneric
05/2021 - 06/2017
4Cisplatin (Platino)FDA LinkGeneric
04/2020 - 03/2009
4InterleukinsIBA
01/2018 - 07/2010
4Anti-Bacterial Agents (Antibiotics)IBA
11/2016 - 07/2009
4Cytidine DeaminaseIBA
04/2016 - 09/2011
4Cholinergic Agents (Cholinergics)IBA
07/2014 - 11/2010
3Docetaxel (Taxotere)FDA Link
04/2022 - 02/2019
3IpilimumabIBA
02/2022 - 12/2019
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2022 - 01/2020
3InterferonsIBA
11/2021 - 04/2016
3Cell Adhesion Molecule-1IBA
05/2021 - 01/2018
3Carboplatin (JM8)FDA LinkGeneric
05/2021 - 12/2017
3secukinumabIBA
08/2018 - 02/2017
3Interleukin-23 (Interleukin 23)IBA
01/2018 - 07/2014
3Imiquimod (Aldara)FDA LinkGeneric
01/2018 - 07/2014
3DNA (Deoxyribonucleic Acid)IBA
12/2016 - 05/2012
3tocilizumab (atlizumab)FDA Link
10/2016 - 05/2009
3ThiazolidinedionesIBA
05/2015 - 05/2011
3Interleukin-17 (Interleukin 17)IBA
07/2014 - 01/2011
3Interleukin-4 (Interleukin 4)IBA
12/2011 - 03/2008
3Interferon-gamma (Interferon, gamma)IBA
12/2011 - 03/2008
2Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 08/2021
2Glutens (Glutelin)IBA
01/2022 - 05/2021
2Adalimumab (Humira)FDA Link
01/2022 - 02/2017
2CreatinineIBA
01/2022 - 07/2013
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 02/2017
2Tyrosine Kinase InhibitorsIBA
01/2022 - 02/2017
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2021 - 01/2018
2Cell Adhesion MoleculesIBA
11/2021 - 05/2021
2Histamine (Histamine Dihydrochloride)FDA Link
08/2021 - 02/2011
2LigandsIBA
07/2021 - 04/2010
2Antimicrobial PeptidesIBA
06/2021 - 07/2012
2Dietary FiberFDA Link
05/2021 - 05/2021
2AutoantibodiesIBA
07/2020 - 04/2011
2GemcitabineFDA Link
04/2020 - 12/2017
2Immunoglobulin E (IgE)IBA
11/2019 - 07/2012

Therapy/Procedure

18Drug Therapy (Chemotherapy)
10/2022 - 08/2012
18Therapeutics
04/2022 - 10/2002
9Prostatectomy (Retropubic Prostatectomy)
02/2020 - 06/2002
8Castration
04/2022 - 01/2019
7Radiotherapy
01/2022 - 06/2010
3Immunotherapy
11/2021 - 10/2002
2Nephrectomy
01/2022 - 09/2017
2Intravenous Administration
11/2021 - 01/2015
2Lymph Node Excision (Lymph Node Dissection)
02/2020 - 06/2010
2Renal Dialysis (Hemodialysis)
11/2019 - 11/2016